[1] LUSTBERG M,SILBERGELD E. Blood lead levels and mortality[J]. Arch Intern Med,2002,162(21):2443-2449. [2] AOKI Y,BRODY D J,FLEGAL K M,et al. Blood lead and other metal biomarkers as risk factors for cardiovascular disease mortality[J]. Medicine (Baltimore),2016,95(1):e2223. [3] 陈侃,王长谦. 模式生物斑马鱼在心血管疾病研究中的应用[J]. 自然杂志,2013(1):64-72. [4] DENIER C,LABAUGE P,BERGAMETTI F,et al. Genotype-phenotype correlations in cerebral cavernous malformations patients[J]. Ann Neurol,2006,60(5):550-556. [5] HE Y,ZHANG H,YU L,et al. Stabilization of VEGFR2 signaling by cerebral cavernous malformation 3 is critical for vascular development[J]. Sci Signal,2010,3(116):a26. [6] CHAN A C,DRAKOS S G,RUIZ O E,et al. Mutations in 2 distinct genetic pathways result in cerebral cavernous malformations in mice[J]. J Clin Invest,2011,121(5):1871-1881. [7] FIDALGO M,GUERRERO A,FRAILE M,et al. Adaptor protein cerebral cavernous malformation 3(CCM3) mediates phosphorylation of the cytoskeletal proteins ezrin/radixin/moesin by mammalian Ste20-4 to protect cells from oxidative stress[J]. J Biol Chem,2012,287(14):11556-11565. [8] 张晓. 中国水污染趋势与治理制度[J]. 中国软科学,2014(10):11-24. [9] WESTERFIELD M. The Zebrafish Book[M]. Oregon:University of Oregon Press,1995. [10] YORUK B,GILLERS B S,CHI N C,et al. CCM3 functions in a manner distinct from Ccm1 and Ccm2 in a zebrafish model of CCM vascular disease[J]. Dev Biol,2012,362(2):121-131. [11] 曹梦思,陈锦瑶,张立实. 铅的心血管系统毒性研究进展[J]. 卫生研究,2014(6):1051-1056. [12] JI A,WANG F,LUO W,et al. Lead poisoning in China:a nightmare from industrialisation[J]. Lancet,2011,377(9776):1474-1476. [13] MEYER P A,BROWN M J,FALK H. Global approach to reducing lead exposure and poisoning[J]. Mutat Res,2008, 659(1/2):166-175. [14] BARBOSA F J,TANUS-SANTOS J E,GERLACH R F,et al. A critical review of biomarkers used for monitoring human exposure to lead:advantages,limitations,and future needs[J]. Environ Health Perspect,2005,113(12):1669-1674. [15] BOULDAY G,BLECON A,PETIT N,et al. Tissue-specific conditional CCM2 knockout mice establish the essential role of endothelial CCM2 in angiogenesis:implications for human cerebral cavernous malformations[J]. Dis Model Mech,2009, 2(3/4):168-177. [16] MABLY J D,CHUANG L P,SERLUCA F C,et al. Santa and valentine pattern concentric growth of cardiac myocardium in the zebrafish[J]. Development,2006,133(16):3139-3146. [17] STAHL S,GAETZNER S,VOSS K,et al. Novel CCM1, CCM2,and CCM3 mutations in patients with cerebral cavernous malformations:in-frame deletion in CCM2 prevents formation of a CCM1/CCM2/CCM3 protein complex[J]. Hum Mutat,2008,29(5):709-717. [18] WHITEHEAD K J,PLUMMER N W,ADAMS J A,et al. CCM1 is required for arterial morphogenesis:implications for the etiology of human cavernous malformations[J]. Development, 2004, 131(6):1437-1448. [19] ZAWISTOWSKI J S,STALHEIM L,UHLIK M T,et al. CCM1 and CCM2 protein interactions in cell signaling:implications for cerebral cavernous malformations pathogenesis[J]. Hum Mol Genet,2005,14(17):2521-2531. [20] ZHANG J,RIGAMONTI D,DIETZ H C,et al. Interaction between krit1 and malcavernin:implications for the pathogenesis of cerebral cavernous malformations[J]. Neurosurgery, 2007,60(2):353-359. [21] WIDZIOLEK M,PRAJSNAR T K,TAZZYMAN S,et al. Zebrafish as a new model to study effects of periodontal pathogens on cardiovascular diseases[J]. Sci Rep,2016,6:36023. [22] PELSTER B,BURGGREN W W. Disruption of hemoglobin oxygen transport does not impact oxygen-dependent physiological processes in developing embryos of zebra fish (Danio rerio)[J]. Circ Res,1996,79(2):358-362. [23] KALOGIROU S,MALISSOVAS N,MORO E,et al. Intracardiac flow dynamics regulate atrioventricular valve morphogenesis[J]. Cardiovasc Res,2014,104(1):49-60. [24] MOULTON J D,YAN Y L. Using Morpholinos to control gene expression[J]. Curr Protoc Mol Biol,2008,26:26-28. [25] 许嘉宁,陈燕. 我国水污染现状[J]. 广东化工,2014,41(3):143-144. [26] 刘伟成,单乐州,谢起浪,等. 生物监测在水环境污染监测中的应用[J]. 环境与健康杂志,2008,25(5):456-459. |